Busting the myths around the Tobacco and Vapes Bill

The Tobacco and Vapes Bill has successfully passed through Parliament and is set to become law, marking a significant public health achievement. The legislation aims to gradually raise the age of sale for tobacco products, starting from 2027, ensuring that individuals born on or after January 1, 2009, can never legally purchase tobacco. This measure is designed to prevent a new generation from becoming addicted to a deadly product, as smoking remains the leading cause of cancer in the UK, responsible for approximately 40,700 cancer deaths annually. The Bill also grants governments powers to expand smokefree and vape-free zones, regulate vape flavors and packaging, and require retailers to hold licenses. Crucially, the law does not criminalize smoking or penalize adults who currently smoke; it focuses solely on the sale of tobacco. Cancer Research UK emphasizes that while this policy aims to create the UK's first smokefree generation, it must be supported by robust enforcement and sustained efforts to help current smokers quit. The organization argues that tobacco is not a standard consumer product due to its addictive nature and lethal consequences, and that the policy is a necessary public health intervention rather than an infringement on personal choice. Addressing concerns about black markets and tax revenue, the article cites historical data showing that previous tobacco control measures did not lead to significant illicit trade. Furthermore, the Bill includes regulations for vaping to minimize youth uptake, while acknowledging that vapes are less harmful than smoking but still require careful oversight. The article concludes by highlighting the broader context of cancer prevention, noting that while tobacco is the primary focus, Cancer Research UK also advocates for action on alcohol and obesity to reduce the overall burden of cancer on the NHS.

(Source：Cancer Research UK - Cancer News)